Recent nanoengineered therapeutic advancements in sepsis management
2024

Advancements in Nanotechnology for Sepsis Management

publication Evidence: moderate

Author Information

Author(s): Liu Li, Wang Ting, Li Zheyu, Yan Bingpeng, Tan Ruirong, Zeng Anqi, Ma Wenbo, Zhu Xin, Yin Zhujun, Ma Chunhua

Primary Institution: Sichuan Institute for Translational Chinese Medicine, Sichuan Academy of Chinese Medicine Sciences, Chengdu, China

Hypothesis

Nanomedicines can improve the management of sepsis through targeted drug delivery and enhanced therapeutic efficacy.

Conclusion

Nanomedicines show significant potential in improving sepsis management by enhancing drug delivery and reducing side effects.

Supporting Evidence

  • Nanomedicines can target and control the release of bio-active agents, improving therapeutic efficacy.
  • Recent advancements in nanotechnology have shown promise in addressing the limitations of conventional sepsis therapies.
  • Nanomaterials can be engineered for specific targeting, enhancing their effectiveness in treating sepsis.

Takeaway

Scientists are using tiny materials called nanomedicines to help treat sepsis better, making medicines work more effectively and with fewer side effects.

Methodology

This review summarizes the preparation and efficacy of various categories of anti-sepsis nanomedicines.

Limitations

The review highlights the need for more attention to safety, regulatory laws, and cost-effectiveness in clinical translation.

Digital Object Identifier (DOI)

10.3389/fbioe.2024.1495277

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication